Title: Nucleic Acid Microparticles for Pulmonary Delivery
Patent Number: 8,808,747
Filed: April 17, 2008
Inventor: Larry Brown, Baxter Healthcare
Title: shRNA Molecules and Methods of Use Thereof
Patent Number: 8,808,983
Filed: June 29, 2012
Inventor: Donald Rao, Gradalis
Title: Compositions and Methods for Altering Wnt Autocrine Signaling
Patent Number: 8,809,287
Filed: Nov. 15, 2005
Lead Inventor: Anna Bafico, Mount Sinai
Title: Double-stranded Nucleic Acid Molecule, Cancer Cell Proliferation Inhibitor, and Pharmaceutical Agent Suitable for Prevention or Treatment of Cancer
Patent Number: 8,809,289
Filed: Sept. 10, 2010
Lead Inventor: Satoshi Inoue, Saitama Medical University (RNAi Co.)
Title: Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
Patent Number: 8,809,292
Filed: May 15, 2012
Lead Inventor: Pamela Tan, Alnylam Pharmaceuticals
Title: Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus
Patent Number: 8,809,293
Filed: June 28, 2012
Lead Inventor: Daniel Chin, Arrowhead Research
Title: Method of Inhibiting miR-33 Using a Modified Oligo Nucleotide
Patent Number: 8,809,294
Filed: July 2, 2012
Lead Inventor: Christine Esau, Regulus Therapeutics
Title: Tripartite Oligonucleotide Complexes and Methods for Gene Silencing by RNA Interference
Patent Number: 8,809,514
Filed: Sept. 20, 2007
Lead Inventor: Christina Yamada, GE Healthcare (Dharmacon)
Title: Methods and Compositions for the Specific Inhibition of Gene Expression by Double-stranded RNA
Patent Number: 8,809,515
Filed: July 8, 2011
Lead Inventor: John Rossi, City of Hope
Title: Therapeutic Compositions
Patent Number: 8,809,516
Filed: Sept. 25, 2012
Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals
Title: Method of Inhibiting Alu RNA and Therapeutic Uses Thereof
Patent Number: 8,809,517
Filed: June 1, 2011
Inventor: Jayakrishna Ambati, University of Kentucky